BR0205932A - Método e composição para tratamento de hipertensão ocular e glaucoma - Google Patents

Método e composição para tratamento de hipertensão ocular e glaucoma

Info

Publication number
BR0205932A
BR0205932A BR0205932-0A BR0205932A BR0205932A BR 0205932 A BR0205932 A BR 0205932A BR 0205932 A BR0205932 A BR 0205932A BR 0205932 A BR0205932 A BR 0205932A
Authority
BR
Brazil
Prior art keywords
treatment
glaucoma
composition
ocular hypertension
day
Prior art date
Application number
BR0205932-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of BR0205932A publication Critical patent/BR0205932A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR0205932-0A 2001-08-23 2002-08-22 Método e composição para tratamento de hipertensão ocular e glaucoma BR0205932A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31411001P 2001-08-23 2001-08-23
PCT/JP2002/008446 WO2003018025A1 (en) 2001-08-23 2002-08-22 Method and composition for treatment of ocular hypertension and glaucoma

Publications (1)

Publication Number Publication Date
BR0205932A true BR0205932A (pt) 2004-02-17

Family

ID=23218598

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0205932-0A BR0205932A (pt) 2001-08-23 2002-08-22 Método e composição para tratamento de hipertensão ocular e glaucoma

Country Status (12)

Country Link
US (1) US20030060511A1 (enExample)
EP (1) EP1420793A1 (enExample)
JP (1) JP2004521960A (enExample)
KR (1) KR20040029012A (enExample)
CN (1) CN1575178A (enExample)
AR (1) AR036276A1 (enExample)
BR (1) BR0205932A (enExample)
CA (1) CA2458230A1 (enExample)
MX (1) MXPA04001604A (enExample)
NO (1) NO20031779D0 (enExample)
WO (1) WO2003018025A1 (enExample)
ZA (1) ZA200302911B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003082257A2 (en) * 2002-03-28 2003-10-09 Sucampo Ag Method for treating ocular hypertension and glaucoma
AR043161A1 (es) * 2003-02-14 2005-07-20 Sucampo Pharmaceuticals Inc Composicion oftalmica para tratar hipertension ocular y glaucoma
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US12478503B2 (en) 2009-05-18 2025-11-25 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
WO2012137987A1 (en) * 2011-04-07 2012-10-11 Sucampo Ag Method for treating asthenopia

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932389A (en) * 1974-12-11 1976-01-13 Pfizer Inc. 2-Descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-.omega.-pentanorprostaglandins
US5212200A (en) * 1987-09-18 1993-05-18 R-Tech Ueno, Ltd. Ocular hypotensive agents
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
EP0569046B1 (en) * 1988-09-06 2002-11-13 Pharmacia Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US6187813B1 (en) * 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
ATE162074T1 (de) * 1988-10-01 1998-01-15 R Tech Ueno Ltd Oculare hypotensive mittel
US5194429A (en) * 1988-10-01 1993-03-16 K.K. Ueno Seiyaku Oyo Kenkyujo Ocular hypotensive agents
TW249226B (enExample) * 1990-04-04 1995-06-11 Aderk Ueno Kk
US5208256A (en) * 1990-05-22 1993-05-04 R-Tech Ueno, Ltd. Treatment of ocular hypertension with a synergistic combination for ocular administration
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
AU687906B2 (en) * 1993-12-15 1998-03-05 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
TW420611B (en) * 1995-03-10 2001-02-01 R Tech Ueno Ltd Pharmaceutical composition containing prostanoic acid compounds for the treatment of optic nerve disorder
AU7680096A (en) * 1995-12-22 1997-07-17 Alcon Laboratories, Inc. Combinations of dp and fp type prostaglandins for lowering iop
US6458836B1 (en) * 2000-03-16 2002-10-01 Sucampo, A.G. Treatment of ocular hypertension and glaucoma
US20020035148A1 (en) * 2000-07-20 2002-03-21 Ryuji Ueno Treatment of ocular hypertension

Also Published As

Publication number Publication date
CA2458230A1 (en) 2003-03-06
WO2003018025A1 (en) 2003-03-06
NO20031779L (no) 2003-04-22
MXPA04001604A (es) 2004-07-08
CN1575178A (zh) 2005-02-02
AR036276A1 (es) 2004-08-25
EP1420793A1 (en) 2004-05-26
JP2004521960A (ja) 2004-07-22
NO20031779D0 (no) 2003-04-22
US20030060511A1 (en) 2003-03-27
KR20040029012A (ko) 2004-04-03
ZA200302911B (en) 2003-10-14

Similar Documents

Publication Publication Date Title
TWI255714B (en) Method for treating meibomian gland disease
ES2062102T3 (es) Derivados de prostaglandinas para el tratamiento de glaucoma o hipertension ocular.
KR930001913A (ko) 안염 치료방법
PT639563E (pt) Utilizacao de ester de isopropilo de fluprostenol para a producao de um medicamento para o tratamento do glaucoma e hipertensao ocular
BR9808016A (pt) Composições e métodos para redução da hipertensão ocular
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
BR0016012A (pt) Implante farmacêutico contendo componentes de liberação imediata e de liberação prolongada, além de processo de administração
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
ATE119776T1 (de) Den augeninnendruck vermindernde 11- acylprostaglandine.
ECSP034815A (es) "composiciones de timolol y de lipido hipotensivas y los metodos para utilizarlas"
BR0208727A (pt) Eritropoietina melhorando a toxicidade in vivo induzida por quimioterapia
KR960033452A (ko) 시신경 질환의 치료를 위한 프로스타노산 화합물
BR9913955A (pt) Composição oftalmológica confortável e de liberação sustentada e método para terapia ocular
KR940003564A (ko) 특정 질환의 예방 및 치료용 약제를 제조하기 위한 c1- 불활성제화제의 용도
BR0205932A (pt) Método e composição para tratamento de hipertensão ocular e glaucoma
BR0209063A (pt) Medicamentos e kits de uso medicinal
DK1091733T3 (da) (-)-Pseudoephedrin som et sympatomimetisk lægemiddel
AU609807B2 (en) A composition for the topical treatment of glaucoma or ocular hypertension
DE69834638D1 (de) Heilende zusammensetzung für intraokulare hypertension oder glaukom
BR0209601A (pt) Método para o tratamento da hipertensão ocular e do glaucoma
BR0211545A (pt) Método e composição para tratamento de hipertensão ocular e glaucoma
SE9401087D0 (sv) New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
KR910019622A (ko) 안과용 상승적 병용으로 안고혈압의 치료
ES2106852T3 (es) Composicion oftalmica que contiene hemihidrato de timolol.
CA2402597A1 (en) Composition for use in treatment of ocular hypertension and glaucoma

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]